DNM1L and metabolic disease: Extensive research has indicated a strong correlation between post-translational modifications of Drp1 and prevalent chronic conditions, including neurodegenerative diseases (Bhatti et al., 2023), cardiovascular diseases (Umezu et al., 2020), and metabolic diseases (Kugler et al., 2021).